Dr. Elizabeth Plimack, MD, MS, FASCO, is a Professor of Medical Oncology and the Deputy Director of Fox Chase Cancer Center. A recognized leader in the treatment of genitourinary malignancies, Dr. Plimack’s work primarily focuses on bladder and kidney cancers. At Fox Chase Cancer Center, Dr. Plimack and her team have pioneered an innovative approach to bladder preservation in patients with muscle-invasive bladder cancer (MIBC). Through clinical trials like RETAIN-1 and RETAIN-2, they are challenging traditional treatment paradigms by exploring systemic therapy-based strategies as alternatives to radical ...
Expert Interviews
Advertisement
Drs. Saji and Lebastchi explore focal therapy, covering its historical evolution, techniques, and energy modalities.
Dr. Ghazi is recognized as a pioneer in patient-specific surgical simulation, using state-of-the-art techniques in surgery.
Dr. Brad McGregor shares exciting developments in the MIBC space and the challenges facing the field of GU oncology.
Dr. Kane shares insights into his career trajectory, highlighting moments that led him to specialize and lead in urology.
Dr. Li rationalizes the design and potential impact of the MoonRISe-1 study for intermediate-risk NMIBC.
Dr. Miles-Thomas shares the challenges of female urology and her vision for her tenure as AUA treasurer.
Advertisement